Please log in to view this page
Username
Password
ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...
We will address our hypothesis using a case-control study design. We plan to leverage the existing biorepository of...
The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...
This study is being done in people who are starting HIV treatment and who live in areas where the TB infection rate is high. The...
Study of MDR TB Cases and Their Household Contacts: Operational Feasibility to Inform PHOENIx Trial Design
